Publisher
Springer Science and Business Media LLC
Subject
Nephrology,Pediatrics, Perinatology, and Child Health
Reference32 articles.
1. Cammas B, Harambat J, Bertholet-Thomas A, Bouissou F, Morin D, Guigonis V, Bendeddouche S, Afroukh-Hacini N, Cochat P, Llanas B, Decramer S, Ranchin B (2011) Long-term effects of cyclophosphamide therapy in steroid-dependent or frequently relapsing idiopathic nephrotic syndrome. Nephrol Dial Transplant 26:178–184. https://doi.org/10.1093/ndt/gfq405
2. Nishi S, Ubara Y, Utsunomiya Y, Okada K, Obata Y, Kai H, Kiyomoto H, Goto S, Konta T, Sasatomi Y, Sato Y, Nishino T, Tsuruya K, Furuichi K, Hoshino J, Watanabe Y, Kimura K, Matsuo S (2016) Evidence-based clinical practice guidelines for nephrotic syndrome 2014. Clin Exp Nephrol 20:342–370. https://doi.org/10.1007/s10157-015-1216-x
3. Martinelli R, Pereira L, Silva O, Okumura A, Rocha H (2004) Cyclophosphamide in the treatment of focal segmental glomerulosclerosis. Braz J Med Biol Res 37:1365–1372. https://doi.org/10.1590/s0100-879x2004000900011
4. Shohet I, Meyerovitch J, Aladiem M, Boichis H (1988) Cyclophosphamide in treatment of minimal change nephrotic syndrome. Eur J Pediatr 147:239–241. https://doi.org/10.1007/BF00442686
5. Ponticelli C, Edefonti A, Ghio L, Rizzoni G, Rinaldi S, Gusmano R, Lama G, Zacchello G, Confalonieri R, Altieri P, Bettinelli A, Maschio G, Cinotti GA, Fuiano G, Schena FP, Castellani A, Delia Casa-Alberighi O (1993) Cyclosporin versus cyclophosphamide for patients with steroid-dependent and frequently relapsing idiopathic nephrotic syndrome: a multicentre randomized controlled trial. Nephrol Dial Transplant 8:1326–1332